Mortality in bullous pemphigoid and prognostic factors in 1st and 3rd year of follow-up in specialized centre in Poland

[1]  Yanhong Wang,et al.  Prognostic factors for mortality in patients with bullous pemphigoid: a meta-analysis , 2017, Archives of Dermatological Research.

[2]  D. Zillikens,et al.  Prevalence and Age Distribution of Pemphigus and Pemphigoid Diseases in Germany. , 2016, The Journal of investigative dermatology.

[3]  W. Lambert,et al.  Bullous pemphigoid and its association with neurological diseases: a systematic review and meta‐analysis , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[4]  K. Tasanen,et al.  Risk of Death in Bullous Pemphigoid: A Retrospective Database Study in Finland. , 2016, Acta dermato-venereologica.

[5]  N. Narayanan,et al.  Autoantibodies to Collagen XVII Are Present in Parkinson's Disease and Localize to Tyrosine-Hydroxylase Positive Neurons. , 2016, The Journal of investigative dermatology.

[6]  A. Serwin,et al.  Incidence and mortality of bullous pemphigoid in north‐east Poland (Podlaskie Province), 1999–2012: a retrospective bicentric cohort study , 2014, International journal of dermatology.

[7]  J. H. Lee,et al.  Mortality of patients with bullous pemphigoid in Korea. , 2014, Journal of the American Academy of Dermatology.

[8]  M. Camilleri,et al.  Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009. , 2014, Journal of the American Academy of Dermatology.

[9]  M. Tang,et al.  Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the National Skin Centre , 2014, The British journal of dermatology.

[10]  S. Rojas-Farreras,et al.  Mortality of bullous pemphigoid in the first year after diagnosis: a retrospective study in a Spanish medical centre , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  L. Naldi,et al.  Mortality Rate in Bullous Pemphigoid: A Retrospective Monocentric Cohort Study , 2012, Dermatology.

[12]  P. Courville,et al.  Incidence and mortality of bullous pemphigoid in France. , 2012, The Journal of investigative dermatology.

[13]  H. Shimizu,et al.  Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. , 2012, Journal of the American Academy of Dermatology.

[14]  L. Naldi,et al.  Mortality of bullous pemphigoid in Switzerland: a prospective study , 2011, The British journal of dermatology.

[15]  Jiang Chen,et al.  Sera of Elderly Bullous Pemphigoid Patients with Associated Neurological Diseases Recognize Bullous Pemphigoid Antigens in the Human Brain , 2010, Gerontology.

[16]  N. Korman,et al.  Mortality of bullous pemphigoid: an evaluation of 223 patients and comparison with the mortality in the general population in the United States. , 2008, Journal of the American Academy of Dermatology.

[17]  R. Hubbard,et al.  Bullous pemphigoid and pemphigus vulgaris—incidence and mortality in the UK: population based cohort study , 2008, BMJ : British Medical Journal.

[18]  A. Ormerod,et al.  Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North‐east Scotland , 2005, The British journal of dermatology.

[19]  J. Roujeau,et al.  Prediction of survival for patients with bullous pemphigoid: a prospective study. , 2005, Archives of dermatology.

[20]  J. Bystryn,et al.  Why is the mortality of bullous pemphigoid greater in Europe than in the US? , 2005, The Journal of investigative dermatology.

[21]  J. Roujeau,et al.  Response to: mortality rate of bullous pemphigoid in a US medical center. , 2005, The Journal of investigative dermatology.

[22]  I. García-Doval,et al.  Sepsis associated with dermatologic hospitalization is not the cause of high mortality of bullous pemphigoid in Europe. , 2005, The Journal of investigative dermatology.

[23]  J. Fairley,et al.  Mortality rate of bullous pemphigoid in a US medical center. , 2004, The Journal of investigative dermatology.

[24]  M. Meurer,et al.  Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age. , 2002, Archives of dermatology.

[25]  L. Vaillant,et al.  A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. , 2002, The New England journal of medicine.

[26]  D. Zillikens,et al.  Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence. , 1999, Journal of the American Academy of Dermatology.

[27]  J. Roujeau,et al.  High risk of death in elderly patients with extensive bullous pemphigoid. , 1998, Archives of dermatology.

[28]  J. Bonnetblanc,et al.  Anti‐BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients , 1997, The British journal of dermatology.

[29]  E. Bröcker,et al.  Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. , 1995, Archives of dermatology.

[30]  D. Fivenson,et al.  Nicotinamide and tetracycline therapy of bullous pemphigoid. , 1994, Archives of dermatology.

[31]  F. Wojnarowska,et al.  Lack of predictive factors for the clinical course of bullous pemphigoid. , 1992, Journal of the American Academy of Dermatology.

[32]  J. Maize,et al.  Bullous Pemphigoid: Clinical and Immunologic Follow-up After Successful Therapy , 1977 .

[33]  P. Hartikainen,et al.  Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer's Disease. , 2017, The Journal of investigative dermatology.

[34]  Jun Li,et al.  Mortality of bullous pemphigoid in China. , 2013, JAMA dermatology.

[35]  Chun-di He,et al.  Treatment and mortality rate of bullous pemphigoid in China: a hospital-based study. , 2013, European journal of dermatology : EJD.